We are live on ! Find out more
GALT icon

Galectin Therapeutics

93 hedge funds and large institutions have $12.7M invested in Galectin Therapeutics in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

0.48% more ownership

Funds ownership: 16.2%16.67% (+0.48%)

2% less capital invested

Capital invested by funds: $13M → $12.7M (-$284K)

1% less funds holding

Funds holding: 9493 (-1)

40% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 30

71% less call options, than puts

Call options by funds: $757K | Put options by funds: $2.57M

Holders
93
Holders Change
-1
Holders Change %
-1.06%
% of All Funds
1.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
18
Reduced
30
Closed
12
Calls
$757K
Puts
$2.57M
Net Calls
-$1.81M
Net Calls Change
-$72K
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
-$1.82K -1,299 -70%
AWM
102
Avior Wealth Management
Nebraska
-$774 -600 Closed
IC
103
Ikarian Capital
Texas
-$129 -100 Closed
AW
104
Avion Wealth
Texas
+$332 +237 New
FIA
105
FNY Investment Advisers
New York
+$842 +600 New